SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-15-002674
Filing Date
2015-05-08
Accepted
2015-05-08 09:00:19
Documents
3
Period of Report
2015-06-19
Effectiveness Date
2015-05-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_050815.htm DEF 14A 702181
2 holliman.jpg GRAPHIC 4042
3 logo.jpg GRAPHIC 7159
  Complete submission text file 0001171843-15-002674.txt   719003
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21214 | Film No.: 15844627
SIC: 2834 Pharmaceutical Preparations